Protein interacting with C alpha kinase 1 (PICK1) is involved in promoting tumor growth and correlates with poor prognosis of human breast cancer.
Protein interacting with C alpha kinase 1 (PICK1), which interacts with multiple different proteins in a variety of cellular contexts, is believed to play important roles in diverse pathological conditions including cancer. In this study, we attempted to investigate the correlation of PICK1 with clinicopathological features as well as prognosis of human breast cancer. In addition, we aimed at a better understanding of the biological function of PICK1 in breast cancer cell biology. As judged by semi- quantitative RT-PCR and western blotting, PICK1 was overexpressed in tumor cells as compared to adjacent normal epithelia in breast, lung, gastric, colorectal, and ovarian cancer. As judged by immunostaining breast cancer tissue microarrays, high levels of PICK1 expression correlated with shortened span of overall survival (OS). Protein interacting with C alpha kinase 1 (PICK1) expression seemed to be specifically associated with reduced OS in lymph node-positive, Her/neu-2 positive, and the basal-like type subgroups, respectively. Consistently, the expression of PICK1 correlated with histological grade, lymph node metastasis, Her-2/neu-positivity, and triple-negative basal-like breast cancer. Protein interacting with C alpha kinase 1 (PICK1) was not correlated with menopausal status, tumor size, or hormone receptor status. In a complementary study, transfection of MDA-MB-231 cells with PICK1 siRNA decreased cell proliferation and colony formation in vitro and inhibited tumorigenicity in nude mice. Our clinical and experimental evidence supports an oncogenic role of PICK1 in human breast cancer. In particular, our data suggest that PICK1 promotes tumor cell proliferation. Taken together, PICK1 may serve not only as a marker for poor prognosis, but also as a therapeutic target in breast cancer.
Zhang
Bin
B
National Key Laboratory of Breast Cancer Prevention and Treatment, Tianjin Medical University, Tianjin, China.
Cao
Wenfeng
W
Zhang
Fei
F
Zhang
Lin
L
Niu
Ruifang
R
Niu
Yun
Y
Fu
Li
L
Hao
Xishan
X
Cao
Xuchen
X
D000818:Animals; D001943:Breast Neoplasms / Q000401:mortality / Q000473:pathology*; D002352:Carrier Proteins / Q000032:analysis / Q000037:antagonists & inhibitors / Q000235:genetics / Q000502:physiology*; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D051379:Mice; D008807:Mice, Inbred BALB C; D009687:Nuclear Proteins / Q000032:analysis / Q000037:antagonists & inhibitors / Q000235:genetics / Q000502:physiology*; D011379:Prognosis; D012189:Retrospective Studies; D023041:Xenograft Model Antitumor Assays
D002352:Carrier Proteins; D009687:Nuclear Proteins; C498297:PICk1 protein, human
Biochem J. 2001 Mar 15;354(Pt 3):635-43
11237868
Eur J Surg Oncol. 2007 May;33(4):409-19
17125963
Lancet Oncol. 2007 Mar;8(3):235-44
17329194
Lancet. 2005 May 14-20;365(9472):1687-717
15894097
Mol Pharmacol. 2001 Nov;60(5):916-23
11641419
Anal Cell Pathol. 1999;19(2):53-8
10746434
J Neurosci. 2000 Oct 1;20(19):7252-7
11007882
Nat Rev Drug Discov. 2004 Dec;3(12):1047-56
15573103
J Cancer Educ. 2006 Spring;21(1 Suppl):S69-79
17020506
Virchows Arch. 2008 Aug;453(2):123-32
18677512
Future Oncol. 2008 Apr;4(2):271-87
18407739
Neuron. 2003 Feb 20;37(4):625-38
12597860
Biochem J. 2002 Feb 1;361(Pt 3):443-50
11802773
Curr Opin Obstet Gynecol. 2008 Feb;20(1):40-6
18197004
Neuron. 2003 Jan 23;37(2):263-74
12546821
Lancet. 1999 May 15;353(9165):1641-8
10335782
Histopathology. 2008 Jan;52(1):108-18
18171422
Neuron. 2001 Apr;30(1):121-34
11343649
Breast Cancer Res Treat. 2008 Feb;107(3):309-30
17377838
Ann Oncol. 2007 Aug;18(8):1293-306
17317675
Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):4029-34
9520487
Neuron. 2000 Nov;28(2):485-97
11144358
Nutr Rev. 2008 Aug;66(8):477-82
18667010
Adv Exp Med Biol. 2007;608:1-22
17993229
J Biol Chem. 2002 Dec 27;277(52):50463-8
12399460
Nature. 1996 Feb 15;379(6566):606-12
8628395
J Cell Sci. 2004 Sep 1;117(Pt 19):4401-9
15304526
Neuron. 1999 Jan;22(1):179-87
10027300
Clin Cancer Res. 2008 Aug 1;14(15):4898-907
18676764
J Biol Chem. 2001 May 4;276(18):15256-63
11278603
J Biol Chem. 2002 Feb 15;277(7):5203-8
11739374
J Clin Oncol. 2006 May 10;24(14):2137-50
16682732
J Biol Chem. 1997 Dec 19;272(51):32019-24
9405395
BMC Cancer. 2008 Mar 28;8:83
18373849
J Clin Oncol. 2008 May 20;26(15):2568-81
18487574
Am J Health Syst Pharm. 2008 Jan 1;65(1):23-8
18159035
Cancer Res. 2007 Jun 1;67(11):5308-17
17545611
J Clin Oncol. 2007 Jan 1;25(1):118-45
17159189
Histopathology. 2008 Jan;52(1):82-90
18171419
Annu Rev Pharmacol Toxicol. 2003;43:261-84
12359863
Ann Surg Oncol. 2007 Sep;14(9):2502-9
17564750
N Engl J Med. 2005 Oct 27;353(17):1784-92
16251534
J Clin Pathol. 2004 Jul;57(7):675-81
15220356
J Cell Biol. 1995 Feb;128(3):263-71
7844141